|
|||||
|
|
| 糖尿病相关性肺纤维化的研究进展 | |
| 引用本文： | 王维越,姜晓艳. 糖尿病相关性肺纤维化的研究进展[J]. 国际呼吸杂志, 2014, 34(20): 1584-1588 |
| 作者姓名： | 王维越 姜晓艳 |
| 作者单位： | 150001,哈尔滨医科大学附属第一医院 |
| 基金项目： | 哈尔滨市科技局科技创新人才 |
| 摘 要： | 近年来,随着对糖尿病肺脏病变研究的不断深入,糖尿病相关性肺纤维化也受到越来越多的关注.研究发现糖尿病肺纤维化主要与氧化应激、血管紧张素Ⅱ、晚期糖基化终末产物及一些细胞因子相关,并发现噻唑烷二酮、他汀类及血管紧张素受体拮抗剂有可能减轻或抑制糖尿病肺纤维化的发生或发展. |
| 关 键 词： | 糖尿病 肺纤维化 药物 |
Research progress in diabetic pulmonary fibrosis |
|
| Wang Weiyue,Jiang Xiaoyan. Research progress in diabetic pulmonary fibrosis[J]. International Journal of Respiration, 2014, 34(20): 1584-1588 | |
| Authors: | Wang Weiyue Jiang Xiaoyan |
| Affiliation: | (The First Hospital affiliated to Harbin Medical University, Harbin 150001 ,China) |
| Abstract: | In the recent years,with the constant lucubration for the diabetic pulmonary disease,diabetic pulmonary fibrosis has received more and more attention.The researchers have found that diabetic pulmonary fibrosis is mainly related with oxidative stress,angiotensin Ⅱ,advaced glycation end products,and some cytokines,and thiazolidinedione,statins,and angiotensin receptor blocker might relieve or suppress occurrence or development of diabetic pulmonary fibrosis. |
| Keywords: | Diabetes mellitus Pulmonary fibrosis Drugs |
| 本文献已被 维普 万方数据 等数据库收录！ | |